What are the Most Important Problems in Drug Design That May Be Computationally Tractable?

Monday, April 7, 1997 - 2:30pm - 3:30pm
Keller 3-180
Tony Hopfinger (University of Illinois, Chicago), Jeffrey Howe (Upjohn Company)
Panel Discussion, Chaired by Jeff Howe and Tony Hopfinger

Dave Doherty, MSI
Bill Dunn, Univ. of Ill., Chicago
W. Graham Richards, Oxford Univ.
Doug Rohrer, Pharmacia/Upjohn